MAGEB3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-56934
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Summary for MAGEB3 Antibody
Immunogen
Synthetic peptides corresponding to MAGEB3(melanoma antigen family B, 3) The peptide sequence was selected from the N terminal of MAGEB3.
Peptide sequence KKKVSFSSPLILGATIQKKSAGRSRSALKKPQRALSTTTSVDVSYKKSYK. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for MAGEB3 Antibody
Western Blot: MAGEB3 Antibody [NBP1-56934]
Western Blot: MAGEB3 Antibody [NBP1-56934] - Human Brain lysate, concentration 0.2-1 ug/ml.Applications for MAGEB3 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: MAGEB3
Alternate Names
CT3.5, MAGE-B3 antigen, melanoma antigen family B, 3, melanoma-associated antigen B3, member 5
Gene Symbol
MAGEB3
UniProt
Additional MAGEB3 Products
Product Documents for MAGEB3 Antibody
Product Specific Notices for MAGEB3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...